EMBO Molecular Medicine (Mar 2017)

Antibodies inhibit transmission and aggregation of C9orf72 poly‐GA dipeptide repeat proteins

  • Qihui Zhou,
  • Carina Lehmer,
  • Meike Michaelsen,
  • Kohji Mori,
  • Dominik Alterauge,
  • Dirk Baumjohann,
  • Martin H Schludi,
  • Johanna Greiling,
  • Daniel Farny,
  • Andrew Flatley,
  • Regina Feederle,
  • Stephanie May,
  • Franziska Schreiber,
  • Thomas Arzberger,
  • Christoph Kuhm,
  • Thomas Klopstock,
  • Andreas Hermann,
  • Christian Haass,
  • Dieter Edbauer

DOI
https://doi.org/10.15252/emmm.201607054
Journal volume & issue
Vol. 9, no. 5
pp. 687 – 702

Abstract

Read online

Abstract Cell‐to‐cell transmission of protein aggregates is an emerging theme in neurodegenerative disease. Here, we analyze the dipeptide repeat (DPR) proteins that form neuronal inclusions in patients with hexanucleotide repeat expansion C9orf72, the most common known cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Sense and antisense transcripts of the (G4C2)n repeat are translated by repeat‐associated non‐ATG (RAN) translation in all reading frames into five aggregating DPR proteins. We show that the hydrophobic DPR proteins poly‐GA, poly‐GP, and poly‐PA are transmitted between cells using co‐culture assays and cell extracts. Moreover, uptake or expression of poly‐GA induces nuclear RNA foci in (G4C2)80‐expressing cells and patient fibroblasts, suggesting an unexpected positive feedback loop. Exposure to recombinant poly‐GA and cerebellar extracts of C9orf72 patients increases repeat RNA levels and seeds aggregation of all DPR proteins in receiver cells expressing (G4C2)80. Treatment with anti‐GA antibodies inhibits intracellular poly‐GA aggregation and blocks the seeding activity of C9orf72 brain extracts. Poly‐GA‐directed immunotherapy may thus reduce DPR aggregation and disease progression in C9orf72 ALS/FTD.

Keywords